FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Police say criminal illegal alien injured 4 officers in Nebraska gas station shootout

NYC mayor-elect tells residents how to resist ICE agents knocking at their door in new video

Oklahoma trooper helps deliver newborn on highway shoulder: ‘The baby is coming!’

Congress unveils $900B defense bill targeting China with tech bans, investment crackdown, US troop pay raise

Trump adds his birthday as free national park day while axing MLK Day and Juneteenth

Obama Proves He’s Stuck in the Past, Offers Desperate Defense of Legacy Media

In Texas cattle country, one rancher welcomes Trump’s focus on decades of thin margins

MTG says she was denied security detail despite 773 death threats

A Detailed Account of the Nightmarish National Guard Shooting: Court Docs

Pearl Harbor remembrance ceremony marks 84 years since attack

Under the New ‘Trump Accounts,’ Your Baby Could Qualify for $1K: Here’s What to Know

Hamline University student brags on video that he celebrated Charlie Kirk’s assassination

Newsom team torched for image posted in response to mocking of gov’s ‘testicle-crushing’ sitting pose

Democrats escalate war-crime accusations as White House calls ‘innocent fisherman’ the new ‘Maryland Man’ hoax

First-Graders Leap Into Action and Save Their Teacher from Choking in Virginia Classroom

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”